跳至主要内容
临床试验/JPRN-jRCT1091220161
JPRN-jRCT1091220161已完成Unknown

The clinical effects of supplementation with a omega-6/omega-3 ratio of 4/1 and its related lipid signaling in individuals with autism spectrum disorders - Efficacy of supplementation with omegs-6/omegs-3 ratio of 4/1

main researcher in this study0 个研究点目标入组 50 人开始时间: 2014年2月5日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
50

研究概览

简要总结

Supplementation with omega-6/omrga-3 ratio of 4/1 remarkably improved ASD symptoms and upregulation of signaling.

研究设计

研究类型
Interventional

入排标准

年龄范围
> 6age old 至 <= 25age old(—)
性别
All

入选标准

  • The Structured Clinical Interview (SCID) for the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) (First et al., 2002) was employed for diagnoses. For diagnoses of ASD, the semi-structured clinical interview based on the Autism Diagnostic Interview Revised (ADI-R) (Rutter et al., 2003) was also used.

排除标准

  • (1) the presence of clinically significant abnormal laboratory data; (2) the presence of neurological disorders or sensory abnormalities; (3)a total IQ of less than 80

研究者

发起方
main researcher in this study

相似试验